- Home
- Healthy Blue Medical Policies
- Genetic Testing for Lipoprotein A Variant as a Decision Aid for Aspirin Treatment and/or CVD Risk Assessment
Genetic Testing for Lipoprotein A Variant as a Decision Aid for Aspirin Treatment and/or CVD Risk Assessment - CAM 344HB
- Category:
- Laboratory
- Department:
- Medical Affairs
- Original Date:
- January 2024
- Last Reviewed:
- January 2025
- Next Review:
- January 2026
{}